
    
      A randomized, open-label, 2-sequence, 2-period, single-dose cross-over clinical trial to
      investigate the pharmacokinetics incorporating a comparison of fed/fasted pharmacokinetics of
      Besifovir dipivoxil in healthy volunteers
    
  